학술논문

Persistent hypercalciuria and elevated 25-hydroxyvitamin D[sub 3] in children with infantile hypercalcaemia.
Document Type
Article
Source
Pediatric Nephrology. 1997, Vol. 11 Issue 1, p2. 5p.
Subject
*HYPERCALCEMIA
*METABOLISM
*CALCIUM phosphate
Language
ISSN
0931-041X
Abstract
The aim of the study was to characterize abnormalities of calcium-phosphate and vitamin D[sub 3] metabolism in children with a past history of "mild" Lightwoodtype idiopathic infantile hypercalcaemia. Seventeen seemingly healthy children aged 2-12 years, with long-term idiopathic hypercalcaemic syndrome since infancy were studied. Two reference groups were also included (vitamin D[sub 3] intoxication/healthy and Williams groups). Despite a long-term milk-restricted diet and a restricted vitamin D[sub 3] intake, urinary calcium excretion in the study group was 0.117±0.07 mmol/kg per 24 h. Compared with the reference groups (0.047±0.029 and 0.067±0.06 mmol/kg per 24 h, P<0.05), there was significant hypercalciuria in the children with idiopathic hypercalcaemia since infancy. Serum concentrations of 25-hydroxyvitamin D[sub 3] in the study group were also elevated compared with the reference groups (57.4±15.5 vs. 34.6±9.3 and 22.7±10.5 ng/ml). 1,25-Dihydroxyvitamin D[sub 3] levels were at the upper limit of normal (45.9±13.1 vs. 35.0±8.1 and 30.0±13.7 pg/ml). Non-progressive, clinically silent nephrocalcinosis was visible on ultrasound examinations. The disturbances of vitamin D[sub 3] and calcium-phosphate metabolism persistent in the normocalcaemic phase of idiopathic infantile hypercalcaemia may be a primary metabolic defect of the condition. The mechanisms leading to elevation of metabolites of 1,25-dihydroxy- and 25-hydroxyvitamin D[sub 3] and the relationship between this and persistent hypercalciuria and nephrocalcinosis need pathophysiological explanation. [ABSTRACT FROM AUTHOR]